Substance use disorders - principles of harm reduction

Definition

Harm reduction aims to minimise the negative health, social, and legal consequences of ongoing substance use without requiring abstinence as a precondition for support - a pragmatic complement to (not a replacement for) abstinence-focused treatment, meeting patients at whatever stage of readiness for change they are currently at
An increasingly mainstream component of substance use disorder management given evidence of reduced transmission of bloodborne viruses, reduced overdose deaths, and improved engagement with health services where harm reduction services are available

Providing practical means to reduce specific harms (clean injecting equipment reducing bloodborne virus transmission, supervised injecting facilities reducing fatal overdose risk, naloxone distribution enabling bystander overdose reversal) directly addresses concrete, preventable harms regardless of whether the underlying substance use itself has stopped - this pragmatic focus on harm reduction rather than use cessation is the defining philosophical distinction from abstinence-only approaches

Non-judgemental engagement and trust-building through harm reduction services often serves as an entry point to eventual treatment engagement for patients not yet ready to consider abstinence, illustrating harm reduction and treatment-focused approaches as complementary rather than competing strategies

Needle and syringe programmes reduce bloodborne virus (HIV, hepatitis B/C) transmission among people who inject drugs
Take-home naloxone programmes equip patients and their contacts to reverse opioid overdose in the community, directly reducing overdose mortality
Opioid agonist treatment itself functions partly as harm reduction (reducing injecting-related harms and overdose risk) even when full abstinence is not the immediate patient goal

Needle and syringe programme evidence base (bloodborne virus transmission reduction), take-home naloxone and bystander overdose reversal, supervised injecting facilities (context-dependent availability and evidence), harm reduction as a pathway to eventual treatment engagement

Harm reduction and abstinence-focused treatment are complementary, not competing, strategies - harm reduction services often build the trust and engagement that eventually facilitates treatment entry for patients not yet ready for abstinence, making a purely abstinence-only service model less effective at reaching and ultimately helping this population than one incorporating harm reduction

5 more sections, plus exam facts

Premium unlocks every note across every specialty, and the full exam fact library behind it.